<DOC>
	<DOCNO>NCT01388543</DOCNO>
	<brief_summary>This study evaluate blood level atazanavir accord genetic makeup CYP3A5 ( cytochrome P450 3A5 , enzyme metabolizes atazanavir ) . The hypothesis people slow-metabolizing genotype would higher blood level atazanavir compare people normal metabolize genotype .</brief_summary>
	<brief_title>Genetics HIV-1 Protease Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Age 18 55 year Negative HIV screen antibody test CYP3A5 expressor status , race , sex fit enrollment opening . Pregnant breastfeed Medical history hepatitis B C , autoimmune disease , active malignancy , kidney disease include nephrolithiasis Organ dysfunction manifest liver transaminase serum creatinine &gt; 1.25 time upper limit normal , comprehensive metabolic test ( except asymptomatic unconjugated hyperbilirubinemia ) , blood count , lipid value &gt; Grade I accord Division AIDS ( DAIDS ) adverse drug event grade system ( appendix ) . Medical history arrhythmia ( include atrial fibrillation , atrioventricular block , and/or pacemaker ) Any QT interval abnormality congenital arrhythmia syndrome ECG ECG abnormality opinion investigator would preclude entry study . Medical history serious heart condition include congestive heart failure , myopathy , coronary artery disease , unexplained syncope . Medical history bleeding disorder ( i.e. , hemophilia ) Hyperlipidemia Any prescription , herbal , recreational , overthecounter medication contraindicate ritonavir atazanavir include , substrates/inhibitors/inducers CYP3A/Pgp , cardioactive medication , medication alter acid stomach . The study investigator review concurrent medication casebycase basis . Inability refrain grapefruit grapefruit juice study . Investigational drug within last 30 day . Active alcohol / recreational drug abuse , inability give inform consent . A body mass index 18.5 34 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Clinical Pharmacology</keyword>
	<keyword>Pharmacogenomics</keyword>
	<keyword>HIV</keyword>
</DOC>